# Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

> **NCT01471067** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 33 (actual)

## Conditions studied

- Blood And Marrow Transplantation
- Leukemia
- Lymphoma
- Transplantation Infection
- Transplantation, Bone Marrow

## Interventions

- **DRUG:** Melphalan
- **DRUG:** Fludarabine
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Tacrolimus
- **PROCEDURE:** Cord Blood Infusion
- **DRUG:** Rituximab
- **DRUG:** ATG
- **DRUG:** Busulfan
- **DRUG:** Clofarabine
- **RADIATION:** Total Body Irradiation (TBI)

## Key facts

- **NCT ID:** NCT01471067
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-13
- **Primary completion:** 2017-04-25
- **Final completion:** 2017-04-25
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471067, "Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01471067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*